SatroecgS.A.
Research and experimental development in natural sciences and engineering
Overview
Satroecg is a company that supports early cardiology diagnostics by assessing ischemic changes in the myocardium. It offers SATRO software, a medical device undergoing certification, which analyzes spatial-temporal electric potentials on the chest surface during left ventricle activity. The software is compatible with ECG devices from most manufacturers and provides immediate access to enhanced diagnostic information.
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 1999-10-13. Active
13 1090 1405 0000 0001 4883 6798- 40 1090 1405 0000 0001 4883 6797
- 77 1090 1405 0000 0001 4883 7004
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
18 public aid cases recorded, with a total value of $1,607,691.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 29, 2024 | Aid for research and development projects: industrial research | —— | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Nov 29, 2024 | Aid for research and development projects: experimental development | —— | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Jul 3, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | —— | Starosta Powiatu Poznań |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
The following are authorised to submit declarations of will and sign on behalf of the company: - in the case of a one-person management board – the President of the Management Board independently; - in the case of a multi-member management board – two members of the management board acting jointly or one member of the management board jointly with a commercial proxy.
Supervisory board
Beneficial owners
| Person | Rights | |
|---|---|---|
Maciej Józef Duda (53)  | Zgłaszana osoba fizyczna posiada więcej niż 25% ogółu certyfikatów w funduszu pod firmą opoka q fundusz inwestycyjny zamknięty (rfi 281), który fudnusz posiada 49,78% akcji w zgłaszanej spółce | |
Bogna Maria Duda-Jankowiak (49) | Zgłaszana osoba fizyczna posiada więcej niż 25% ogółu certyfikatów w funduszu pod firmą opoka q fundusz inwestycyjny zamknięty (rfi 281), który fudnusz posiada 49,78 % akcji w zgłaszanej spółce | |
Jerzy Stanisław Janicki (70) | Shareholder of a joint-stock company, 32.73% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Active Textsp. z o.o. | $409,418.80 | active-text.pl | ||
| Digital Pathology Team Witold Reznersp. k. | $383,078.99 | digitalpathologyteam.com | ||
| BiocamS.A. | $327,799.68 | biocam.ai | ||
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| AI Corelabsp. z o.o. | $106,857.00 | aicorelab.com | ||
| Sentisasp. z o.o. | $98,401.32 | sentisa.com | ||
| Biostat Research and Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| Advanced Diagnostic Equipmentsp. z o.o. | $43,171.56 | adediabetics.pl | ||
| Edoktor24 Servicessp. z o.o. | $34,089.64 | edoktor24.pl | ||
| SimplicardiacS.A. | $28,951.71 | simplicardiac.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-09-12 | Share capital change (123,243.00 PLN → 141,689.00 PLN) | |
| 2025-09-12 | PKD change (Removed: 22.29.Z, 32.99.Z, 47.19.Z, 47.99.Z, 62.01.Z, 64.19.Z, 64.99.Z, 72.19.Z, 86.90.E; Added: 32.50.B, 47.74.Z, 62.10.B, 62.90.Z, 63.10.D, 72.10.Z, 85.59.B, 86.21.Z, 86.99.D) | |
| 2024-06-17 | Share capital change (116,100.00 PLN → 123,243.00 PLN) | |
| 2023-10-23 | Share capital change (107,500.00 PLN → 116,100.00 PLN) | |
| 2022-03-29 | Address change (Ul. Ludwika Solskiego 14, 62-040, Puszczykowo → Ul. Macieja Palacza 144, 60-278, Poznań) |
FAQ
Last updated: 2026-09-23